
The Margin Squeeze: How Medicare Negotiations and AI Diagnostics are Bifurcating the Healthcare Sector
The enforcement of Medicare drug price negotiations, coupled with massive GLP-1 manufacturing expansions and aggressive FTC antitrust actions, is fund...
Read Full Story →



![[Healthcare Policy's Structural Fracture: Medicare Advantage Cliffs, Antitrust Paradoxes, and the Algorithmic Compliance Moat]](https://www.crimaz.com/assets/images/no-image.png)

